Skip to main content

Rock Springs Capital Management LP

13F filer · CIK 0001595725
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$2.05BU.S. long equity reported on 13F
Positions10416 new · 11 closed
Net flow last quarter-$9.82MBuys minus sells
Top 10 positions weight44.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026104 positions
RVMDRevolution Medicines, Inc.$207M10.10%0.52%-8.6%Q1 2023
TVTXTravere Therapeutics, Inc.$124M6.04%2.31%+47.4%Q4 2020
LLYELI LILLY & Co$118M5.78%0.01%Not reportedQ1 2015
MDGLMadrigal Pharmaceuticals, Inc.$94M4.59%0.76%+2.3%Q3 2016
MIRMMirum Pharmaceuticals, Inc.$93.4M4.56%1.23%-1.6%Q3 2019
RYTMRhythm Pharmaceuticals, Inc.$76.9M3.75%1.01%+0.4%Q4 2017
KYMRKymera Therapeutics, Inc.$52M2.54%0.55%-8.8%Q3 2020
ARGXArgenx SE$48.9M2.39%0.09%-46.5%Q2 2018
ASNDAscendis Pharma A/S$45M2.20%0.27%-13.0%Q1 2015
XENEXenon Pharmaceuticals Inc.$41.3M2.01%0.71%-10.4%Q1 2020
SRRKScholar Rock Holding Corp$39.3M1.92%0.59%-3.3%Q4 2024
INSMINSMED Inc$38.6M1.88%0.17%+15.2%Q1 2015
PENPenumbra Inc$36.5M1.78%0.29%-3.9%Q3 2015
GPCRStructure Therapeutics Inc.$34.4M1.68%0.30%0.0%Q4 2023
RAREUltragenyx Pharmaceutical Inc.$32.3M1.58%0.98%-20.6%Q1 2014
IRTCiRhythm Holdings, Inc.$32.1M1.57%0.82%+3.0%Q3 2017
ISRGIntuitive Surgical Inc$30.4M1.48%0.02%-6.8%Q4 2013
AGLagilon health, inc.$28.1M1.37%1.56%+1.0%Q2 2021
UNHUnitedhealth Group Inc$26.5M1.29%0.01%+20.3%Q4 2013
CLDXCelldex Therapeutics, Inc.$26M1.27%0.89%+7.5%Q1 2022
ERASErasca, Inc.$25.7M1.25%0.45%+27.1%Q4 2025
NBIXNeurocrine Biosciences Inc$24.4M1.19%0.14%-3.8%Q1 2014
ELVNEnliven Therapeutics, Inc.$23.6M1.15%0.63%-43.8%Q1 2024
THCTenet Healthcare Corp$23.4M1.14%0.15%Not reportedQ4 2024
DXCMDexcom Inc$23.1M1.13%0.09%-3.5%Q1 2021
ACRSAclaris Therapeutics, Inc.$22.9M1.12%3.10%-3.2%Q4 2015
MMEDMiniMed Group, Inc.$22.7M1.11%0.54%+44.1%Q1 2026
BSXBoston Scientific Corp$22.6M1.10%0.04%+2.6%Q2 2018
PHVSPharvaris N.V.$22.4M1.09%0.99%+0.4%Q1 2024
AVLNAvalyn Pharma Inc.$21.8M1.07%1.50%NewQ2 2026
COAGHemab Therapeutics Holdings, Inc.$21.1M1.03%1.23%NewQ2 2026
DYNDyne Therapeutics, Inc.$20.9M1.02%0.57%-3.1%Q1 2024
ALNYAlnylam Pharmaceuticals, Inc.$20.1M0.98%0.05%-9.8%Q2 2017
COGTCogent Biosciences, Inc.$20M0.97%0.30%-17.3%Q2 2025
AGIOAgios Pharmaceuticals, Inc.$19.8M0.96%0.89%-33.4%Q1 2019
NAMSNewAmsterdam Pharma Co N.V.$19.7M0.96%0.50%-1.0%Q3 2024
VERAVera Therapeutics, Inc.$18.3M0.90%0.60%-15.1%Q1 2024
TARSTarsus Pharmaceuticals, Inc.$17.4M0.85%0.64%+23.1%Q4 2024
HTFLHeartflow, Inc.$16.8M0.82%0.66%+0.2%Q3 2025
MBXMBX Biosciences, Inc.$16.5M0.80%0.62%+3.6%Q3 2025
CYTKCytokinetics Inc$16M0.78%0.15%+314.4%Q2 2020
BCAXBicara Therapeutics Inc.$15.9M0.78%0.81%+9.4%Q3 2024
PBLSParabilis Medicines, Inc.$15.8M0.77%0.47%NewQ2 2026
ZLABZai Lab Ltd$15.5M0.76%0.07%Not reportedQ3 2017
DHRDanaher Corp$14.5M0.71%0.01%+24.1%Q3 2014
TNGXTango Therapeutics, Inc.$14.3M0.70%0.27%+18.0%Q4 2025
EVHEvolent Health, Inc.$13.6M0.66%2.22%-6.5%Q1 2021
PTCTPTC Therapeutics, Inc.$13.2M0.65%0.19%+0.3%Q1 2015
MLYSMineralys Therapeutics, Inc.$13.1M0.64%0.55%+10.3%Q1 2023
ZBIOZenas BioPharma, Inc.$12.7M0.62%0.79%Not reportedQ3 2024
Q1 2026Reported May 15, 202699 positions
RVMDRevolution Medicines, Inc.$118M6.93%0.60%-9.4%Q1 2023
LLYELI LILLY & Co$90.8M5.35%0.01%-6.4%Q1 2015
MDGLMadrigal Pharmaceuticals, Inc.$89.5M5.28%0.74%+22.5%Q3 2016
MIRMMirum Pharmaceuticals, Inc.$74.9M4.42%1.33%+6.4%Q3 2019
ARGXArgenx SE$71.9M4.24%0.16%-4.6%Q2 2018
RYTMRhythm Pharmaceuticals, Inc.$60M3.54%1.01%-0.8%Q4 2017
INSMINSMED Inc$51.4M3.03%0.15%-1.6%Q1 2015
ASNDAscendis Pharma A/S$44.4M2.62%0.31%-4.7%Q1 2015
XENEXenon Pharmaceuticals Inc.$44.4M2.62%0.79%-3.1%Q1 2020
TVTXTravere Therapeutics, Inc.$43.9M2.59%1.60%-33.1%Q4 2020
KYMRKymera Therapeutics, Inc.$41.4M2.44%0.60%Not reportedQ3 2020
PENPenumbra Inc$39.6M2.33%0.31%Not reportedQ3 2015
ISRGIntuitive Surgical Inc$37.8M2.23%0.02%Not reportedQ4 2013
SRRKScholar Rock Holding Corp$36.4M2.14%0.62%+0.9%Q4 2024
ELVNEnliven Therapeutics, Inc.$32.4M1.91%1.36%+3.5%Q1 2024
BSXBoston Scientific Corp$32.3M1.91%0.03%+29.1%Q2 2018
IRTCiRhythm Holdings, Inc.$30.9M1.82%0.80%+11.4%Q3 2017
GPCRStructure Therapeutics Inc.$30.9M1.82%0.30%-14.4%Q4 2023
AGIOAgios Pharmaceuticals, Inc.$27M1.59%1.35%Not reportedQ1 2019
RAREUltragenyx Pharmaceutical Inc.$25.5M1.50%1.24%-3.8%Q1 2014
ALNYAlnylam Pharmaceuticals, Inc.$24.5M1.44%0.06%+3.9%Q2 2017
COGTCogent Biosciences, Inc.$24M1.42%0.37%-26.5%Q2 2025
THCTenet Healthcare Corp$23.6M1.39%0.14%Not reportedQ4 2024
DXCMDexcom Inc$22.3M1.32%0.09%+2.4%Q1 2021
CLDXCelldex Therapeutics, Inc.$20.6M1.22%0.98%-6.1%Q1 2022
VERAVera Therapeutics, Inc.$20.3M1.19%0.79%-11.4%Q1 2024
NBIXNeurocrine Biosciences Inc$19.8M1.17%0.15%+19.9%Q1 2014
ACLXArcellx, Inc.$19.5M1.15%0.29%Not reportedQ2 2025
NAMSNewAmsterdam Pharma Co N.V.$18.8M1.11%0.50%+5.7%Q3 2024
PHVSPharvaris N.V.$18.2M1.07%0.99%+3.6%Q1 2024
ERASErasca, Inc.$17.9M1.05%0.36%+16.0%Q4 2025
DYNDyne Therapeutics, Inc.$17.6M1.04%0.59%+6.5%Q1 2024
CMPXCompass Therapeutics, Inc.$17.5M1.03%1.84%-15.8%Q4 2021
ACRSAclaris Therapeutics, Inc.$16.8M0.99%3.20%+0.4%Q4 2015
TARSTarsus Pharmaceuticals, Inc.$15.8M0.93%0.52%-13.5%Q4 2024
MMEDMiniMed Group, Inc.$15.7M0.93%Not reportedNewQ1 2026
ZLABZai Lab Ltd$15.3M0.90%0.07%+0.4%Q3 2017
UNHUnitedhealth Group Inc$14.3M0.85%0.01%+29.9%Q4 2013
CNTACentessa Pharmaceuticals PLC$14M0.82%0.23%+8.6%Q3 2025
HTFLHeartflow, Inc.$13.9M0.82%0.66%+106.2%Q3 2025
ARDXArdelyx, Inc.$13.8M0.81%0.93%Not reportedQ2 2015
SMMTSummit Therapeutics Inc.$13.5M0.79%0.09%Not reportedQ3 2024
AZTAAzenta, Inc.$12M0.71%1.23%Not reportedQ2 2022
MLYSMineralys Therapeutics, Inc.$11.9M0.70%0.53%+2.8%Q1 2023
DHRDanaher Corp$11.7M0.69%0.01%Not reportedQ3 2014
PTCTPTC Therapeutics, Inc.$11M0.65%0.20%+161.5%Q1 2015
CAICaris Life Sciences, Inc.$10.1M0.59%0.20%-18.1%Q2 2025
ZBIOZenas BioPharma, Inc.$9.82M0.58%0.80%Not reportedQ3 2024
BCAXBicara Therapeutics Inc.$9.73M0.57%0.75%+14.0%Q3 2024
BBIOBridgeBio Pharma, Inc.$9.52M0.56%0.07%+23.9%Q3 2025
Q4 2025Reported Feb 17, 202696 positions
LLYELI LILLY & Co$113M5.81%0.01%Not reportedQ1 2015
RVMDRevolution Medicines, Inc.$106M5.45%0.68%Not reportedQ1 2023
ARGXArgenx SE$86.8M4.45%0.17%-27.7%Q2 2018
TVTXTravere Therapeutics, Inc.$84.5M4.33%2.43%+2.1%Q4 2020
MDGLMadrigal Pharmaceuticals, Inc.$81.3M4.17%0.61%+1.4%Q3 2016
RYTMRhythm Pharmaceuticals, Inc.$74.4M3.81%1.03%-3.1%Q4 2017
EXKEndeavour Silver Corp$61.1M3.13%0.23%+1.4%Q3 2016
MIRMMirum Pharmaceuticals, Inc.$60.2M3.09%1.47%+0.2%Q3 2019
INSMINSMED Inc$55.6M2.85%0.15%-17.1%Q1 2015
GPCRStructure Therapeutics Inc.$52M2.67%0.35%-21.3%Q4 2023
ISRGIntuitive Surgical Inc$46.4M2.38%0.02%Not reportedQ4 2013
CDTXCidara Therapeutics, Inc.$45.3M2.32%0.65%-17.9%Q2 2015
ASNDAscendis Pharma A/S$43.4M2.23%0.33%-5.1%Q1 2015
IRTCiRhythm Holdings, Inc.$41.7M2.14%0.73%Not reportedQ3 2017
KYMRKymera Therapeutics, Inc.$38.7M1.98%0.61%+10.3%Q3 2020
BSXBoston Scientific Corp$38M1.95%0.03%+10.8%Q2 2018
PENPenumbra Inc$37.5M1.92%0.31%Not reportedQ3 2015
XENEXenon Pharmaceuticals Inc.$35.3M1.81%0.98%-7.5%Q1 2020
SRRKScholar Rock Holding Corp$32.3M1.66%0.68%-7.6%Q4 2024
COGTCogent Biosciences, Inc.$30.2M1.55%0.53%-15.8%Q2 2025
RAREUltragenyx Pharmaceutical Inc.$29.1M1.49%1.31%+1.7%Q1 2014
VERAVera Therapeutics, Inc.$28.8M1.48%0.89%-7.9%Q1 2024
ALNYAlnylam Pharmaceuticals, Inc.$28.3M1.45%0.05%-4.0%Q2 2017
FOLDAmicus Therapeutics, Inc.$27.5M1.41%0.62%-0.9%Q2 2015
THCTenet Healthcare Corp$24.8M1.27%0.14%Not reportedQ4 2024
DXCMDexcom Inc$23.1M1.18%0.09%+9.6%Q1 2021
AGIOAgios Pharmaceuticals, Inc.$21.8M1.12%1.37%-16.6%Q1 2019
TARSTarsus Pharmaceuticals, Inc.$21.3M1.09%0.61%-9.7%Q4 2024
CMPXCompass Therapeutics, Inc.$21.1M1.08%2.20%-12.2%Q4 2021
NAMSNewAmsterdam Pharma Co N.V.$19.5M1.00%0.49%-6.5%Q3 2024
AZTAAzenta, Inc.$18.9M0.97%1.24%+5.3%Q2 2022
CLDXCelldex Therapeutics, Inc.$18.8M0.96%1.04%-4.0%Q1 2022
CAICaris Life Sciences, Inc.$18.5M0.95%0.24%-13.4%Q2 2025
ZBIOZenas BioPharma, Inc.$18.2M0.93%0.92%-13.5%Q3 2024
DYNDyne Therapeutics, Inc.$17.9M0.92%0.55%+10.8%Q1 2024
NBIXNeurocrine Biosciences Inc$17.8M0.91%0.13%+39.8%Q1 2014
PHVSPharvaris N.V.$17.3M0.89%0.96%Not reportedQ1 2024
MLYSMineralys Therapeutics, Inc.$15.5M0.80%0.52%+4.7%Q1 2023
PHRPhreesia, Inc.$14.8M0.76%1.45%+17.0%Q3 2019
ZLABZai Lab Ltd$14.3M0.73%0.07%+2.6%Q3 2017
DHRDanaher Corp$14.1M0.72%0.01%Not reportedQ3 2014
UNHUnitedhealth Group Inc$13.5M0.69%0.00%Not reportedQ4 2013
ARDXArdelyx, Inc.$13.4M0.69%0.94%+0.6%Q2 2015
ACRSAclaris Therapeutics, Inc.$13.4M0.69%3.70%-3.4%Q4 2015
SMMTSummit Therapeutics Inc.$12.4M0.64%0.09%Not reportedQ3 2024
ELVNEnliven Therapeutics, Inc.$12.3M0.63%1.34%+16.4%Q1 2024
INSPInspire Medical Systems, Inc.$12.1M0.62%0.46%+18.6%Q1 2020
OMDAOmada Health, Inc.$11.7M0.60%1.27%-19.6%Q2 2025
SLNOSoleno Therapeutics Inc$11.4M0.59%0.47%+59.9%Q4 2024
ACLXArcellx, Inc.$11.1M0.57%0.29%-5.1%Q2 2025
Q3 2025Reported Nov 14, 202590 positions
ARGXArgenx SE$105M6.15%0.23%-18.8%Q2 2018
LLYELI LILLY & Co$80.4M4.70%0.01%-9.5%Q1 2015
RYTMRhythm Pharmaceuticals, Inc.$72.4M4.23%1.08%-16.7%Q4 2017
MDGLMadrigal Pharmaceuticals, Inc.$63.2M3.69%0.61%-1.8%Q3 2016
RVMDRevolution Medicines, Inc.$62.4M3.64%0.70%+0.3%Q1 2023
MRUSMerus N.V.$56.2M3.28%0.79%-43.9%Q2 2016
MIRMMirum Pharmaceuticals, Inc.$55.8M3.26%1.48%-7.0%Q3 2019
INSMINSMED Inc$55.4M3.24%0.18%-26.7%Q1 2015
TVTXTravere Therapeutics, Inc.$51.7M3.02%2.42%+13.5%Q4 2020
ASNDAscendis Pharma A/S$42.6M2.49%0.35%-1.2%Q1 2015
IRTCiRhythm Holdings, Inc.$40.4M2.36%0.73%-3.1%Q3 2017
AGIOAgios Pharmaceuticals, Inc.$38.5M2.25%1.64%-3.2%Q1 2019
RAREUltragenyx Pharmaceutical Inc.$37.5M2.19%1.29%-10.4%Q1 2014
ISRGIntuitive Surgical Inc$36.7M2.14%0.02%Not reportedQ4 2013
BSXBoston Scientific Corp$35.2M2.05%0.02%+1.5%Q2 2018
XENEXenon Pharmaceuticals Inc.$34.2M2.00%1.10%-8.6%Q1 2020
ALNYAlnylam Pharmaceuticals, Inc.$33.9M1.98%0.06%-25.8%Q2 2017
EXKEndeavour Silver Corp$32.5M1.90%0.23%+3.8%Q3 2016
PENPenumbra Inc$30.5M1.78%0.31%-6.2%Q3 2015
AKROAkero Therapeutics, Inc.$29.7M1.74%0.78%-2.2%Q2 2019
SRRKScholar Rock Holding Corp$29.6M1.73%0.80%Not reportedQ4 2024
ZLABZai Lab Ltd$26.8M1.57%0.07%-9.2%Q3 2017
GPCRStructure Therapeutics Inc.$26.6M1.56%0.52%-16.3%Q4 2023
KYMRKymera Therapeutics, Inc.$25.5M1.49%0.63%Not reportedQ3 2020
THCTenet Healthcare Corp$25.4M1.48%0.14%-3.9%Q4 2024
EVHEvolent Health, Inc.$25M1.46%2.51%+4.6%Q1 2021
CAICaris Life Sciences, Inc.$24M1.40%0.28%Not reportedQ2 2025
CDTXCidara Therapeutics, Inc.$23.9M1.40%0.85%+85.9%Q2 2015
DXCMDexcom Inc$21.3M1.25%0.08%+10.5%Q1 2021
OMDAOmada Health, Inc.$20.3M1.19%1.59%0.0%Q2 2025
CLDXCelldex Therapeutics, Inc.$18.7M1.09%1.09%-11.2%Q1 2022
VERAVera Therapeutics, Inc.$17.9M1.05%0.97%Not reportedQ1 2024
PHRPhreesia, Inc.$17.6M1.03%1.25%-10.5%Q3 2019
TARSTarsus Pharmaceuticals, Inc.$17.1M1.00%0.68%-22.9%Q4 2024
NAMSNewAmsterdam Pharma Co N.V.$16.9M0.99%0.53%+11.2%Q3 2024
CMPXCompass Therapeutics, Inc.$15.7M0.92%2.52%-9.8%Q4 2021
PHVSPharvaris N.V.$15.6M0.91%1.15%Not reportedQ1 2024
AZTAAzenta, Inc.$15.5M0.91%1.18%+1.9%Q2 2022
MLYSMineralys Therapeutics, Inc.$15.5M0.90%0.52%+25.8%Q1 2023
FOLDAmicus Therapeutics, Inc.$15.3M0.90%0.63%-0.7%Q2 2015
ACLXArcellx, Inc.$14.7M0.86%0.31%-3.9%Q2 2025
SMMTSummit Therapeutics Inc.$14.7M0.86%0.10%Not reportedQ3 2024
COGTCogent Biosciences, Inc.$14.5M0.85%0.72%+26.0%Q2 2025
ELVNEnliven Therapeutics, Inc.$14M0.82%1.16%-2.2%Q1 2024
ZBIOZenas BioPharma, Inc.$12.9M0.75%1.38%-9.3%Q3 2024
NBIXNeurocrine Biosciences Inc$12.6M0.74%0.09%+1.1%Q1 2014
ARDXArdelyx, Inc.$12.6M0.74%0.94%Not reportedQ2 2015
DHRDanaher Corp$12.2M0.71%0.01%+4.2%Q3 2014
LENZLENZ Therapeutics, Inc.$11M0.64%0.83%+181.3%Q4 2024
SLNOSoleno Therapeutics Inc$10.4M0.61%0.29%Not reportedQ4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.